PDB Short entry for 3F9M HEADER TRANSFERASE 14-NOV-08 3F9M TITLE HUMAN PANCREATIC GLUCOKINASE IN COMPLEX WITH GLUCOSE AND ACTIVATOR TITLE 2 SHOWING A MOBILE FLAP COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 12-465; COMPND 5 SYNONYM: HEXOKINASE TYPE IV, HK IV, HEXOKINASE-4, HK4, HEXOKINASE-D; COMPND 6 EC: 2.7.1.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS GLUCOKINASE, HEXOKINASE IV, ATP-BINDING, DIABETES MELLITUS, DISEASE KEYWDS 2 MUTATION, GLYCOLYSIS, KINASE, NUCLEOTIDE-BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.PETIT,L.GLUAIS,A.LAGARDE,L.VUILLARD,J.A.BOUTIN,G.FERRY REVDAT 8 01-NOV-23 3F9M 1 REMARK HETSYN REVDAT 7 29-JUL-20 3F9M 1 COMPND REMARK SEQADV HETNAM REVDAT 7 2 1 SITE REVDAT 6 25-APR-12 3F9M 1 JRNL REVDAT 5 09-NOV-11 3F9M 1 JRNL VERSN REVDAT 4 19-JAN-10 3F9M 1 REMARK REVDAT 3 13-JAN-09 3F9M 1 AUTHOR REVDAT 2 09-DEC-08 3F9M 1 AUTHOR REVDAT 1 02-DEC-08 3F9M 0 JRNL AUTH P.PETIT,M.ANTOINE,G.FERRY,J.A.BOUTIN,A.LAGARDE,L.GLUAIS, JRNL AUTH 2 R.VINCENTELLI,L.VUILLARD JRNL TITL THE ACTIVE CONFORMATION OF HUMAN GLUCOKINASE IS NOT ALTERED JRNL TITL 2 BY ALLOSTERIC ACTIVATORS JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 67 929 2011 JRNL REFN ISSN 0907-4449 JRNL PMID 22101819 JRNL DOI 10.1107/S0907444911036729 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 73275 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3664 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5072 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 267 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3549 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.37000 REMARK 3 B33 (A**2) : -0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.080 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.082 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.056 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.905 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3713 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5000 ; 1.388 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 468 ; 5.157 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;36.658 ;24.144 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 694 ;13.964 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;18.816 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 547 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2802 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2147 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2614 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 479 ; 0.136 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 77 ; 0.185 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 24 ; 0.119 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2299 ; 0.873 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3636 ; 1.393 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1542 ; 2.179 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1356 ; 3.465 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3F9M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050319. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73934 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 19.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 3.250 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1V4S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.85000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.80000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.80000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.85000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.60000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -4 REMARK 465 GLY A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 GLY A 94 REMARK 465 GLU A 95 REMARK 465 GLU A 96 REMARK 465 GLY A 97 REMARK 465 LYS A 459 REMARK 465 ALA A 460 REMARK 465 CYS A 461 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 SER A 398 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 67 CB CG CD OE1 OE2 REMARK 480 GLN A 98 CG CD OE1 NE2 REMARK 480 LYS A 140 CD CE NZ REMARK 480 LYS A 142 CD CE NZ REMARK 480 GLU A 399 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 191 NE - CZ - NH1 ANGL. DEV. = 8.9 DEGREES REMARK 500 ARG A 191 NE - CZ - NH2 ANGL. DEV. = -8.9 DEGREES REMARK 500 ARG A 191 O - C - N ANGL. DEV. = -10.7 DEGREES REMARK 500 ARG A 394 NE - CZ - NH1 ANGL. DEV. = -5.0 DEGREES REMARK 500 ARG A 394 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 85.62 21.84 REMARK 500 PRO A 66 -91.37 -125.28 REMARK 500 GLU A 67 116.48 -179.61 REMARK 500 GLN A 138 71.78 51.83 REMARK 500 MET A 139 16.48 -156.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1V4S RELATED DB: PDB REMARK 900 1V4S WAS OBTAINED WITH A DIFFERENT ISOFORM AT A LOWER PH IN A REMARK 900 DIFFERENT UNIT CELL. THIS RESULTED IN 1V4S IN BLOCKING THE MOBILITY REMARK 900 OF THE ACTIVATOR POCKET FLAP. REMARK 900 RELATED ID: 1V4T RELATED DB: PDB REMARK 900 APO VERSION OF HUMAN GLUCOKINASE DBREF 3F9M A 12 465 UNP P35557 HXK4_HUMAN 12 465 SEQADV 3F9M MET A -4 UNP P35557 EXPRESSION TAG SEQADV 3F9M GLY A -3 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A -2 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A -1 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A 0 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A 1 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A 2 UNP P35557 EXPRESSION TAG SEQADV 3F9M HIS A 3 UNP P35557 EXPRESSION TAG SEQADV 3F9M GLU A 4 UNP P35557 EXPRESSION TAG SEQADV 3F9M ASN A 5 UNP P35557 EXPRESSION TAG SEQADV 3F9M LEU A 6 UNP P35557 EXPRESSION TAG SEQADV 3F9M TYR A 7 UNP P35557 EXPRESSION TAG SEQADV 3F9M PHE A 8 UNP P35557 EXPRESSION TAG SEQADV 3F9M GLN A 9 UNP P35557 EXPRESSION TAG SEQADV 3F9M GLY A 10 UNP P35557 EXPRESSION TAG SEQADV 3F9M MET A 11 UNP P35557 EXPRESSION TAG SEQRES 1 A 470 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 470 GLN GLY MET LYS LYS GLU LYS VAL GLU GLN ILE LEU ALA SEQRES 3 A 470 GLU PHE GLN LEU GLN GLU GLU ASP LEU LYS LYS VAL MET SEQRES 4 A 470 ARG ARG MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU SEQRES 5 A 470 GLU THR HIS GLU GLU ALA SER VAL LYS MET LEU PRO THR SEQRES 6 A 470 TYR VAL ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP SEQRES 7 A 470 PHE LEU SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL SEQRES 8 A 470 MET LEU VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SEQRES 9 A 470 SER VAL LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU SEQRES 10 A 470 ASP ALA MET THR GLY THR ALA GLU MET LEU PHE ASP TYR SEQRES 11 A 470 ILE SER GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN SEQRES 12 A 470 MET LYS HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER SEQRES 13 A 470 PHE PRO VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU SEQRES 14 A 470 LEU ASN TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU SEQRES 15 A 470 GLY ASN ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS SEQRES 16 A 470 ARG ARG GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL SEQRES 17 A 470 ASN ASP THR VAL ALA THR MET ILE SER CYS TYR TYR GLU SEQRES 18 A 470 ASP HIS GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY SEQRES 19 A 470 CYS ASN ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU SEQRES 20 A 470 LEU VAL GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR SEQRES 21 A 470 GLU TRP GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU SEQRES 22 A 470 PHE LEU LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER SEQRES 23 A 470 ALA ASN PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY SEQRES 24 A 470 GLY LYS TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU SEQRES 25 A 470 ARG LEU VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SEQRES 26 A 470 SER GLU GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG SEQRES 27 A 470 PHE VAL SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS SEQRES 28 A 470 GLN ILE TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SEQRES 29 A 470 SER THR THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SEQRES 30 A 470 SER VAL SER THR ARG ALA ALA HIS MET CYS SER ALA GLY SEQRES 31 A 470 LEU ALA GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER SEQRES 32 A 470 GLU ASP VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER SEQRES 33 A 470 VAL TYR LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS SEQRES 34 A 470 ALA SER VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR SEQRES 35 A 470 PHE ILE GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA SEQRES 36 A 470 LEU VAL SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU SEQRES 37 A 470 GLY GLN HET GLC A 500 12 HET MRK A 501 23 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM MRK 2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL) HETNAM 2 MRK SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 3 MRK C14 H12 F N5 O S2 FORMUL 4 HOH *440(H2 O) HELIX 1 1 ASN A 5 ALA A 21 1 17 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 ARG A 46 1 21 HELIX 4 4 PRO A 111 THR A 116 1 6 HELIX 5 5 THR A 118 HIS A 137 1 20 HELIX 6 6 ASN A 180 GLY A 193 1 14 HELIX 7 7 ASN A 204 TYR A 215 1 12 HELIX 8 8 GLN A 239 VAL A 241 5 3 HELIX 9 9 GLU A 256 PHE A 260 5 5 HELIX 10 10 LEU A 266 LEU A 270 5 5 HELIX 11 11 LEU A 271 SER A 281 1 11 HELIX 12 12 GLN A 287 LEU A 292 1 6 HELIX 13 13 GLY A 294 GLU A 312 1 19 HELIX 14 14 LEU A 315 GLU A 319 5 5 HELIX 15 15 GLU A 331 SER A 340 1 10 HELIX 16 16 ARG A 345 LEU A 355 1 11 HELIX 17 17 SER A 360 ARG A 397 1 38 HELIX 18 18 GLY A 410 HIS A 416 1 7 HELIX 19 19 SER A 418 THR A 431 1 14 HELIX 20 20 GLU A 443 CYS A 457 1 15 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O ASN A 254 N LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N TYR A 234 O VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N ILE A 225 O ASN A 231 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N VAL A 222 SHEET 6 A 6 CYS A 434 GLU A 440 1 O THR A 437 N VAL A 406 SHEET 1 B 5 TRP A 99 SER A 109 0 SHEET 2 B 5 ASN A 83 GLY A 92 -1 N PHE A 84 O TYR A 108 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N SER A 76 O MET A 87 SHEET 4 B 5 PRO A 145 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 ASP A 198 VAL A 203 1 O ASP A 198 N LEU A 146 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 CISPEP 1 SER A 64 THR A 65 0 21.65 CISPEP 2 THR A 65 PRO A 66 0 5.50 CRYST1 65.700 81.200 85.600 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015221 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012315 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011682 0.00000